Demonstrate

In order to make informed economic decisions, payers must understand the comparative effectiveness of your product and how it translates into cost efficiencies for their budget. Cornerstone offers a variety of modeling and analytic services that quantify and demonstrate the clinical and economic value of pharmaceutical, medical device, and biotechnology interventions.

Global Cost-effectiveness Models

Global model platforms that can be easily adapted to any market

  • Markov and state transition models
  • Survival partition models
  • Patient simulation models
  • Discrete events simulations
  • Steady state models

Country-specific Analyses

Local analyses for reimbursement and HTA submissions.

  • Experience in all major markets
  • Local clinical and health economic experts
  • Experts in Canadian analyses

Budget Impact Analyses

Estimate the financial consequences of the adoption and diffusion of a new health care intervention to public and private payers.

  • National or managed care perspective
  • Net benefit analyses
  • Hospital budget analyses

Evidence Synthesis

Assess pooled and comparative effectiveness of a new product.

Chart review

Collect data on practice patterns, outcomes and burden of illness.

  • Multi-center, global registries
  • Single- and multi-center chart review
  • Web-based or traditional data entry

Interested in a service that is not listed? Contact us.

Post a Comment

Copyright © 2017. All Rights Reserved. Cornerstone Research Group